Notably, the median AAO for PARK-LRRK2 in this systematic review was 56 years, lower than the median AAO of 60–75 years reported for PD patients in general, consistent with the notion that monogenic causes for PD typically have earlier AAO50. The gene discussed is LRRK2; the disease is Parkinson disease.